Efficacy of oral methotrexate in paediatric Crohn's disease: A multicentre propensity score study

Keyphrases

• Crohn's Disease 100%
• Pediatric Crohn's Disease 100%
• Propensity Score 100%
• Score Study 100%
• Oral Methotrexate 100%
• Methotrexate 66%
• Subcutaneous Methotrexate 66%
• Disease Groups 33%
• Treatment Group 33%
• Patient Well-being 33%
• Complete Remission 33%
• Cost Reduction 33%
• Inflammatory Markers 33%
• Route of Administration 33%
• Steroid-free Remission 33%
• Thiopurines 33%
• Nausea 33%
• Confounding 33%
• Oral Route 33%
• Treatment Escalation 33%
• Height Velocity 33%
• Elevated Liver Enzymes 33%
• Close Monitoring 33%
• Propensity Score Methods 33%
• Weighted Regression Model 33%
• Need for Treatment 33%
• Propensity Score Modeling 33%
• Pretreatment Variables 33%
• 0-1 Test 33%
• Weekly Injection 33%
• Time to Remission 33%
• Doubly Robust Methods 33%

Medicine and Dentistry

• Pediatrics 100%
• Crohn's Disease 100%
• Methotrexate 100%
• Oral 100%
• Effect Size 16%
• Health Care Cost 16%
• Quality of Life 16%
• Cohort Analysis 16%
• Patient with Crohn's Disease 16%
• Mercaptopurine 16%
• Nausea 16%
• Elevated Transaminases 16%
• Amoxicillin Plus Clavulanic Acid 16%
• Treatment Group 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Crohn's Disease 100%
• Methotrexate 100%
• Remission 50%
• Cohort Study 16%
• Route of Administration 16%
• Mercaptopurine 16%
• Nausea 16%
• Hypertransaminasemia 16%
• Amoxicillin Plus Clavulanic Acid 16%
• Treatment Group 16%